Page 46 - Read Online

Page 24 of 25 Kondapuram et al. J Cancer Metastasis Treat 2019;5:32 I http://dx.doi.org/10.20517/2394-4722.2018.105

78. Lazarus MB, Shokat KM. Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1. Bioorganic Med
Chem 2015;23:5483-8.
79. Matsunaga K, Morita E, Saitoh T, Akira S, Ktistakis NT, et al. Autophagy requires endoplasmic reticulum targeting of the PI3-kinase
complex via Atg14L. J Cell Biol 2010;190:511-21.
80. Honda A, Harrington E, Cornella-Taracido I, Furet P, Knapp MS, et al. Potent, selective, and orally bioavailable inhibitors of VPS34
provide chemical tools to modulate autophagy in vivo. ACS Med Chem Lett 2016;7:72-6.
81. Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in
ferritin degradation and iron homeostasis in vivo. Nat Cell Biol 2014;16:1069-79.
82. Pasquier B, El-Ahmad Y, Filoche-Rommé B, Dureuil C, Fassy F, et al. Discovery of (2 S)-8-[(3 R)-3-methylmorpholin-4-yl]-1-(3-methyl-
2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2 H -pyrimido[1,2- a ]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for
the treatment of solid tumors. J Med Chem 2015;58:376-400.
83. Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Mol Cell Oncol
2014;1:e29911.
84. Shi TT, Yu XX, Yan LJ, Xiao HT. Research progress of hydroxychloroquine and autophagy inhibitors on cancer. Cancer Chemother
Pharmacol 2017;79:287-94.
85. Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome
fusion. Autophagy 2018;14:1435-55.
86. Chude CI, Amaravadi RK. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci 2017;18:E1279.
87. Xu R, Ji Z, Xu C, Zhu J. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of
cancers: a systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e12912.
88. Amaravadi RK, Winkler JD. Lys05: a new lysosomal autophagy inhibitor. Autophagy 2012;8:1383-4.
89. McAfee Q, Zhang Z, Samanta A, Levi SM, Ma XH, et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces
the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci 2012;109:8253-8.
90. Kasi PD, Tamilselvam R, Skalicka-Woźniak K, Nabavi SF, Daglia M, et al. Molecular targets of curcumin for cancer therapy: an updated
review. Tumor Biol 2016;37:13017-28.
91. Zhu Y, Bu S. Curcumin induces autophagy, apoptosis, and cell cycle arrest in human pancreatic cancer cells. Evidence-Based
Complement Altern Med 2017;2017:5787218.
92. Xiao K, Jiang J, Guan C, Dong C, Wang G, et al. Curcumin induces autophagy via activating the AMPK signaling pathway in lung
adenocarcinoma cells. J Pharmacol Sci 2013;123:102-9.
93. Kobori M, Takahashi Y, Sakurai M, Akimoto Y, Tsushida T, et al. Quercetin suppresses immune cell accumulation and improves
mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol Nutr Food Res 2016;60:300-12.
94. Lou M, Zhang LN, Ji PG, Feng FQ, Liu JH, et al. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/
Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. Biomed Pharmacother 2016;84:1-9.
95. Liu Y, Gong W, Yang ZY, Zhou XS, Gong C, et al. Quercetin induces protective autophagy and apoptosis through ER stress via the
p-STAT3/Bcl-2 axis in ovarian cancer. Apoptosis 2017;22:544-57.
96. Hwang JJ, Kuruvilla J, Mendelson D, Pishvaian MJ, Deeken JF, et al. Phase I dose finding studies of obatoclax (GX15-070), a small
molecule Pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma. Clin Cancer Res 2010;16:4038-45.
97. Basit F, Cristofanon S, Fulda S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on
autophagosomal membranes. Cell Death Differ 2013;20:1161-73.
98. Yang Y, Chen S, Zhang Y, Lin X, Song Y, et al. Induction of autophagy by spermidine is neuroprotective via inhibition of caspase
3-mediated Beclin 1 cleavage. Cell Death Dis 2017;8:e2738.
99. Sacitharan PK, Lwin S, Gharios GB, Edwards JR. Spermidine restores dysregulated autophagy and polyamine synthesis in aged and
osteoarthritic chondrocytes via EP300. Exp Mol Med 2018;50:123.
100. Welsh PA, Sass-Kuhn S, Prakashagowda C, McCloskey D, Feith D. Spermine synthase overexpression in vivo does not increase
susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis. Cancer Biol Ther 2012;13:358-68.
101. Matsui TA, Murata H, Sakabe T, Sowa Y, Horie N, et al. Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma
cells in vitro and inhibits tumor growth in vivo. Oncol Rep 2007;18:1263-8.
102. Xiao D, Powolny AA, Antosiewicz J, Hahm ER, Bommareddy A, et al. Cellular responses to cancer chemopreventive agent D,L-
sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species. Pharm Res 2009;26:1729-38.
103. Liu H, Smith AJ, Ball SS, Bao Y, Bowater RP, et al. Sulforaphane promotes ER stress, autophagy, and cell death: implications for cataract
surgery. J Mol Med 2017;95:553-64.
104. Wiczk A, Hofman D, Konopa G, Herman-Antosiewicz A. Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein
synthesis in human prostate cancer cells. Biochim Biophys Acta - Mol Cell Res 2012;1823:1295-305.
105. Cohen MH, Johnson JR, Pazdur R. Food and drug administration drug approval summary: temozolomide plus radiation therapy for the
treatment of newly diagnosed glioblastoma multiforme. Clin Cancer Res 2005;11:6767-71.
106. Würstle S, Schneider F, Ringel F, Gempt J, Lämmer F, et al. Temozolomide induces autophagy in primary and established glioblastoma
cells in an EGFR independent manner. Oncol Lett 2017;14:322-8.
107. Dai C, Zhang B, Liu X, Ma S, Yang Y, et al. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in
pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice. Endocrinology 2013;154:1247-59.
108. Chen B, Xiao F, Li B, Xie B, Zhou J, et al. The role of epithelial-mesenchymal transition and IGF-1R expression in prediction of gefitinib
activity as the second-line treatment for advanced nonsmall-cell lung cancer. Cancer Invest 2013;31:454-60.
109. Zhao ZQ, Yu ZY, Li J, Ouyang XN. Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR
pathway. Oncol Lett 2016;12:63-8.